|
Re: Book closes.....
|
3
|
Resverlogix Corp.
|
Jun 04, 2019 04:50PM
|
|
AZ- Another one bites the dust!
|
3
|
Resverlogix Corp.
|
Sep 09, 2019 03:01PM
|
|
Re: Book closes.....
|
3
|
Resverlogix Corp.
|
Jun 04, 2019 05:07PM
|
|
Re: RVX ANNOUNCES TYPE C MEETING WITH FDA FOR CORAL, A PHASE 3 HIGH-RISK COVID-19 OUTPATIENT STUDY
|
3
|
Resverlogix Corp.
|
May 09, 2022 05:09PM
|
|
Re: Article
|
3
|
Resverlogix Corp.
|
May 30, 2022 09:52AM
|
|
Re: Local TV Station Global Calgary
|
3
|
Resverlogix Corp.
|
Mar 12, 2021 11:08AM
|
|
Re: Not on the board, nor bored, but on board
|
3
|
Resverlogix Corp.
|
May 24, 2019 09:18AM
|
|
Re: Share price, why we stay
|
3
|
Resverlogix Corp.
|
Nov 18, 2020 10:46AM
|
|
Re: people whining about the whining
|
3
|
Resverlogix Corp.
|
Dec 23, 2020 05:35PM
|
|
Re: Rationale and Design of Apabetalone BETonMACE Trial
|
3
|
Resverlogix Corp.
|
Jun 02, 2019 10:14AM
|
|
Re: today's trading...
|
3
|
Resverlogix Corp.
|
Feb 16, 2020 10:01AM
|
|
Re: BTI just filed a Other securityholders documents - English
|
3
|
BIOASIS TECHNOLOGIES INC
|
Oct 16, 2018 02:41PM
|
|
Re: Zenith Epigenetics Announces Collaboration with NCI in Developing ZEN-3694 for Multiple Oncology Indications
|
3
|
Zenith Epigenetics
|
Oct 05, 2020 04:43PM
|
|
Re: 2 new upcoming presentations
|
3
|
Resverlogix Corp.
|
May 03, 2020 10:22AM
|
|
Re: Heart failure study
|
3
|
Resverlogix Corp.
|
Feb 09, 2021 05:32PM
|
|
Re: New Covid mutation on the radar -- 'Mu'
|
3
|
Resverlogix Corp.
|
Sep 01, 2021 01:39PM
|
|
Re: Why news has to come out Thursday imo....walking in the enemy's shoes
|
3
|
Resverlogix Corp.
|
Jan 29, 2019 06:47AM
|
|
Re: Resverlogix to Present at the Clinical Trials on Alzheimer's Disease Congress 2019
|
3
|
Resverlogix Corp.
|
Dec 02, 2019 01:49PM
|
|
Re: Zenith Epigenetics Reports Advancement of ZEN-3694 in NUT Carcinoma
|
3
|
Zenith Epigenetics
|
Jun 02, 2023 07:38AM
|
|
Re: Monday
|
3
|
Resverlogix Corp.
|
Oct 02, 2020 06:03AM
|
